![](/img/cover-not-exists.png)
Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC
Yang, Hong, Liu, Zhimin, Wang, Yufang, Li, Jun, Li, Ruiqian, Wang, Qilin, Hu, Chen, Jiang, Haiyang, Wu, Hongyi, Song, Lele, Bai, YuVolume:
12
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835920970845
Date:
January, 2020
File:
PDF, 306 KB
2020